InvestSMART

TrivarX Ltd (ASX: TRI) - Announcements

- Current share price for TRI : $0.009

ASX company news and announcements for TrivarX Ltd (TRI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All TrivarX Ltd (TRI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than TrivarX Ltd (TRI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for TrivarX Ltd (TRI)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$10 Application for quotation of securities - TRI 24 Mar 2025 10:22AM $0.012 $0.009 fallen by 25%
$10 Proposed issue of securities - TRI 17 Mar 2025 9:26AM $0.015 $0.009 fallen by 40%
$10 Proposed issue of securities - TRI 17 Mar 2025 9:26AM $0.015 $0.009 fallen by 40%
$10 TrivarX Receives Firm Commitments to Raise $2.25 million 17 Mar 2025 9:25AM $0.015 $0.009 fallen by 40%
$10 Trading Halt 13 Mar 2025 8:52AM $0.015 $0.009 fallen by 40%
$10 Trial with US Department of Veterans Affairs 13 Mar 2025 8:34AM $0.015 $0.009 fallen by 40%
$10 Appendix 4D & Half-Year Financial Report to 31 December 2024 28 Feb 2025 3:11PM $0.016 $0.009 fallen by 43.75%
$10 December 2024 Quarterly Activities Report and Appendix 4C 31 Jan 2025 8:19AM $0.018 $0.009 fallen by 50%
$10 Positive engagement with FDA following meeting for MEB-001 28 Jan 2025 11:16AM $0.017 $0.009 fallen by 47.06%
$10 Cleansing Notice 14 Jan 2025 5:14PM $0.017 $0.009 fallen by 47.06%
$10 Application for quotation of securities - TRI 14 Jan 2025 5:12PM $0.017 $0.009 fallen by 47.06%
$10 Proposed issue of securities - TRI 13 Jan 2025 11:58AM $0.016 $0.009 fallen by 43.75%
$10 TrivarX Receives $1.03m R&D Tax Incentive 6 Dec 2024 8:20AM $0.017 $0.009 fallen by 47.06%
$10 Change of Director's Interest Notice - Chris Ntoumenopoulos 5 Dec 2024 9:42AM $0.016 $0.009 fallen by 43.75%
$10 Change of Director's Interest Notice - David Trimboli 5 Dec 2024 9:42AM $0.016 $0.009 fallen by 43.75%
$10 Change of Director's Interest Notice - Tony Keating 5 Dec 2024 9:40AM $0.016 $0.009 fallen by 43.75%
$10 Cleansing Notice 5 Dec 2024 8:36AM $0.016 $0.009 fallen by 43.75%
$10 Notification regarding unquoted securities - TRI 5 Dec 2024 8:35AM $0.016 $0.009 fallen by 43.75%
$10 Application for quotation of securities - TRI 4 Dec 2024 5:34PM $0.016 $0.009 fallen by 43.75%
$10 Results of Annual General Meeting 28 Nov 2024 12:22PM $0.015 $0.009 fallen by 40%
$10 Annual General Meeting - Chairman Update 28 Nov 2024 8:21AM $0.015 $0.009 fallen by 40%
$10 New AI Tool Expands Patient Reach and Market Opportunities 7 Nov 2024 8:22AM $0.015 $0.009 fallen by 40%
$10 September 2024 Quarterly Activities Report and Appendix 4C 30 Oct 2024 2:13PM $0.015 $0.009 fallen by 40%
$10 Proposed issue of securities - TRI 28 Oct 2024 12:00PM $0.018 $0.009 fallen by 50%
$10 Letter to Shareholders & Notice of AGM & Proxy Form 28 Oct 2024 10:49AM $0.018 $0.009 fallen by 50%

101 - 125 of 219 results

Page 5 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.